We are live on ! Find out more
BCAB icon

BioAtla
BCAB

39 hedge funds and large institutions have $5.21M invested in BioAtla in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $4.76M → $5.21M (+$458K)

0.02% less ownership

Funds ownership: 0.47% → 0.45% (-0.02%)

5% less funds holding

Funds holding: 41 → 39 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
11
Closed
8
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
ACA
Acorn Capital Advisors
New York
+$326K
2
ACM
ADAR1 Capital Management
Texas
+$69.1K
3
ACI
Alpha Cubed Investments
California
+$16.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$16.7K
5
MCM
MAI Capital Management
Ohio
+$14K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$114K
2
Squarepoint
Squarepoint
New York
-$90.3K
3
GCP
GSA Capital Partners
United Kingdom
-$81K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$80.1K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$70.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
1
Acorn Capital Advisors
New York
$1.91M +$326K +16,061 +20%
Vanguard Group
2
Vanguard Group
Pennsylvania
$706K -$14.1K -697 -2%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$589K -$80.1K -3,951 -12%
TCM
4
Tang Capital Management
California
$544K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$299K +$3.81K +188 +1%
Deutsche Bank
6
Deutsche Bank
Germany
$210K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$195K +$5.27K +260 +3%
BlackRock
8
BlackRock
New York
$190K -$45.8K -2,259 -19%
Morgan Stanley
9
Morgan Stanley
New York
$125K -$114K -5,601 -47%
ACM
10
ADAR1 Capital Management
Texas
$67.5K +$69.1K +3,410 New
State Street
11
State Street
Massachusetts
$59.9K – – –
Northern Trust
12
Northern Trust
Illinois
$39.9K – – –
Two Sigma Investments
13
Two Sigma Investments
New York
$32.7K -$43K -2,119 -56%
Marshall Wace
14
Marshall Wace
United Kingdom
$32.3K -$2.23K -110 -6%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$29.6K +$16.7K +822 +122%
PAM
16
PVG Asset Management
Colorado
$25.7K – – –
MFG
17
Magnus Financial Group
New York
$18.7K – – –
MCM
18
MAI Capital Management
Ohio
$17.5K +$14K +690 +354%
ACI
19
Alpha Cubed Investments
California
$16.3K +$16.7K +823 New
BRWA
20
B. Riley Wealth Advisors
Florida
$11.9K +$12.2K +600 New
UBS Group
21
UBS Group
Switzerland
$11.7K -$7.6K -375 -39%
CAP
22
Columbia Advisory Partners
Washington
$10.3K – – –
Commonwealth Equity Services
23
Commonwealth Equity Services
Massachusetts
$10K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$9.23K +$9.45K +466 New
HF
25
HRT Financial
New York
$8K +$8.41K +415 New
1
2

BCAB Hedge Fund Activity: Q2 2025 in Review

39 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2025, worth a combined $5.21M — up 9.6% from $4.76M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BCAB and 6 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 8 added.

The largest buyer was Acorn Capital Advisors, adding an estimated $326K. The largest seller was Morgan Stanley, cutting an estimated $114K.

  • 39 institutional investors held BioAtla (BCAB) as of Q2 2025, down from 41 in Q1 2025.
  • Funds reported $5.21M of BioAtla stock for Q2 2025, up 9.6% quarter-over-quarter.
  • 6 funds opened new BioAtla positions in Q2 2025 and 8 closed out, a net change of -2 holders.
  • The largest BioAtla buyer in Q2 2025 was Acorn Capital Advisors, an estimated $326K added.
  • The largest BioAtla seller in Q2 2025 was Morgan Stanley, an estimated $114K sold.

Based on aggregated 13F filings for Q2 2025.